Quercetin as a Multi‐Target Natural Therapeutic in Aging‐Related Diseases: Systemic Molecular and Cellular Mechanisms
Phytotherapy Research · 2025-10 · 39 (10) · 4821-4869
DOI: 10.1002/ptr.70078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 13.09.2025. Verfasst von Shengxue Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, Jilin Agricultural Science and Technology College, Jilin, China. Hauptthemen laut MEDLINE: Quercetin, Aging. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 258 Literaturangaben. Gefördert von: National Key R&D Project.
Abstract (Originalsprache)
Quercetin, a flavonol subclass of dietary polyphenols, has garnered significant attention for its multi‐targeted biological activities relevant to aging and chronic degenerative diseases. Acting through potent antioxidant, anti‐inflammatory, anti‐apoptotic, and metabolic regulatory mechanisms, quercetin modulates key molecular pathways implicated in age‐related disorders across multiple systems, including the cardiovascular, skeletal, neurological, metabolic, and ocular domains. This review synthesizes these shared mechanisms to support a systems‐level perspective on quercetin's therapeutic potential. By influencing these signaling cascades, quercetin exerts protective effects across a range of aging‐associated disorders, namely cardiovascular diseases, osteoporosis, cerebrovascular accidents, diabetes, dementia, and eye‐related diseases. This review is based on a comprehensive literature search conducted in PubMed, Scopus, and Web of Science up to March 2025, using keywords related to quercetin, polyphenols, aging, and associated diseases. Articles were selected based on relevance to molecular mechanisms, inclusion of in vitro, in vivo, or clinical data, and publication in peer‐reviewed journals. Preventively, quercetin's capacity to modulate inflammation, oxidative stress, and apoptotic pathways offers promising strategies to delay disease onset and progression. Personalized approaches employing biomarker profiling and advanced delivery systems may optimize quercetin's bioavailability and therapeutic efficacy in targeted patient groups. This review provides a comprehensive overview of the molecular and cellular mechanisms by which quercetin modulates aging processes and age‐related pathologies, and highlights advances aimed at overcoming its bioavailability limitations. Further clinical investigations are warranted to establish optimized dosing regimens and long‐term safety profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicine, Jilin Agricultural Science and Technology College, Jilin, China.
- Dehui Employment Training Center, Dehui, Jilin, China.
- Jilin Jinziyuan Biotechnology Co., Ltd, Shuangliao, Jilin, China.
ORCID-Profile: Shuang Liu
Förderung
- National Key R&D Project
Zitieren
APA
Zhou, S., Qingman, X., Zhang, W., Zhang, D., & Liu, S. (2025). Quercetin as a Multi‐Target Natural Therapeutic in Aging‐Related Diseases: Systemic Molecular and Cellular Mechanisms. Phytotherapy Research, 39(10), 4821-4869. https://doi.org/10.1002/ptr.70078
Vancouver
Zhou S, Qingman X, Zhang W, Zhang D, Liu S. Quercetin as a Multi‐Target Natural Therapeutic in Aging‐Related Diseases: Systemic Molecular and Cellular Mechanisms. Phytotherapy Research. 2025;39(10):4821-4869. doi:10.1002/ptr.70078
BibTeX
@article{Zhou2025,
author = {Zhou, Shengxue and Qingman, Xinshang and Zhang, Wei and Zhang, Dahui and Liu, Shuang},
title = {Quercetin as a Multi‐Target Natural Therapeutic in Aging‐Related Diseases: Systemic Molecular and Cellular Mechanisms},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {10},
pages = {4821--4869},
doi = {10.1002/ptr.70078}
}
EUVIMED